Prostate cancer is one of the most common cancers among men—but new innovations are changing the way we detect and treat it.
Discover how cutting-edge imaging and treatment are changing the way we fight prostate cancer. This session explores the evolving role of PSMA PET imaging in the management of prostate cancer, focusing on its clinical utility in diagnosis and treatment planning. Join us as experts introduce Lutetium PSMA, a breakthrough therapy that targets cancer directly and exploring the promising future of theranostics—an emerging approach that integrates diagnostics and therapeutics to enable more precise, efficient, and personalised prostate cancer care.
